Astronics (Nasdaq: ATRO) reported earnings on Aug. 7. Here are the numbers you need to know.

The 10-second takeaway
For the quarter ended June 30 (Q2), Astronics beat expectations on revenues and missed estimates on earnings per share.

Compared to the prior-year quarter, revenue grew significantly and GAAP earnings per share grew.

Gross margins improved, operating margins dropped, net margins contracted.

Revenue details
Astronics booked revenue of $65.0 million. The three analysts polled by S&P Capital IQ anticipated a top line of $62.2 million on the same basis. GAAP reported sales were 17% higher than the prior-year quarter's $55.5 million.

My

Source: S&P Capital IQ. Quarterly periods. Dollar amounts in millions. Non-GAAP figures may vary to maintain comparability with estimates.

EPS details
EPS came in at $0.39. The three earnings estimates compiled by S&P Capital IQ predicted $0.46 per share. GAAP EPS of $0.39 for Q2 were 11% higher than the prior-year quarter's $0.35 per share.

Source: S&P Capital IQ. Quarterly periods. Non-GAAP figures may vary to maintain comparability with estimates.

Margin details
For the quarter, gross margin was 26.2%, 30 basis points better than the prior-year quarter. Operating margin was 12.0%, 110 basis points worse than the prior-year quarter. Net margin was 8.0%, 20 basis points worse than the prior-year quarter.

Looking ahead
Next quarter's average estimate for revenue is $66.1 million. On the bottom line, the average EPS estimate is $0.44.

Next year's average estimate for revenue is $268.9 million. The average EPS estimate is $1.82.

Investor sentiment
The stock has a five-star rating (out of five) at Motley Fool CAPS, with 300 members out of 314 rating the stock outperform, and 14 members rating it underperform. Among 59 CAPS All-Star picks (recommendations by the highest-ranked CAPS members), 56 give Astronics a green thumbs-up, and three give it a red thumbs-down.

Of Wall Street recommendations tracked by S&P Capital IQ, the average opinion on Astronics is outperform, with an average price target of $42.00.